Apogee Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $130 | $0 |
Gross Profit | -400 | -207 | 65 | -48 |
EBITDA | -73,165 | -63,096 | -75,805 | -58,638 |
EBIT | -73,165 | -63,303 | -75,881 | -58,686 |
Net Income | -66,096 | -55,339 | -67,218 | -49,018 |
Net Change In Cash | 0 | 0 | 130 | 0 |
Free Cash Flow | -62,797 | -52,794 | -67,713 | -43,275 |
Cash | 124,192 | 106,916 | 141,789 | 118,780 |
Basic Shares | 58,428 | 58,195 | 55,193 | 56,795 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -189 | ||
EBITDA | -216,870 | -83,985 | -39,785 |
EBIT | -217,059 | -93,003 | -64,247 |
Net Income | -182,146 | -83,985 | -39,785 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -172,326 | -74,928 | -16,427 |
Cash | 141,789 | 118,316 | 151,890 |
Basic Shares | 55,193 | 50,655 | 50,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.13 |
2025-03-31 | -$0.95 |
2024-12-31 | -$1.18 |
